The endocrine function of the pancreas is to produce hormones that regulate blood sugar, appetite, and digestion. While most of the pancreas (about 95-99% of its tissue) is devoted to producing digestive enzymes, small clusters of hormone-producing cells scattered throughout the organ handle its endocrine role. These clusters, called islets of Langerhans, release hormones directly into the bloodstream, with insulin and glucagon being the most well known.
Where Endocrine Cells Sit in the Pancreas
The pancreas contains roughly one million islets of Langerhans, and they aren’t spread evenly. Islet density progressively increases from the head of the pancreas (the wide end tucked into the curve of your small intestine) toward the tail (the narrow end near your spleen). The tail contains roughly twice the islet density of the head, with the clusters packed closer together. This distribution matters surgically: removing the tail of the pancreas has a greater impact on hormone production than removing the head.
The Five Cell Types Inside Each Islet
Each islet is a miniature organ containing five distinct cell types, each producing a different hormone:
- Beta cells (about 60% of the islet) produce insulin, the hormone that lowers blood sugar by signaling your muscles, fat, and liver to absorb glucose.
- Alpha cells (about 30%) produce glucagon, which raises blood sugar by telling the liver to release its stored glucose.
- Delta cells (about 10%) produce somatostatin, a hormone that acts as a local brake on both insulin and glucagon secretion.
- F cells, also called PP cells (1-2%) produce pancreatic polypeptide, which helps regulate appetite and the speed of digestion.
- Epsilon cells (about 1% in adults) produce ghrelin, the “hunger hormone.” These cells are far more abundant in fetal pancreases (around 10%) and shrink to a small fraction after birth.
How Insulin and Glucagon Balance Blood Sugar
Insulin and glucagon work as a paired system, constantly adjusting to keep your blood sugar within a narrow range. A normal fasting blood sugar level is below 100 mg/dL. The two hormones push it in opposite directions depending on what your body needs at any given moment.
After you eat, rising blood glucose enters beta cells through a specialized transporter. Inside the cell, glucose is broken down to produce energy molecules, and the resulting chemical shift causes the cell to release insulin into the bloodstream. Insulin then signals muscle and fat tissue to pull glucose out of the blood and tells the liver to store glucose for later use. Blood sugar drops back toward its baseline.
Between meals or during exercise, blood sugar starts to fall. Alpha cells respond by secreting glucagon, which triggers the liver to break down its glucose reserves and release them back into the bloodstream. This prevents blood sugar from dropping too low, which would starve the brain and muscles of fuel.
This feedback loop runs continuously, and the two hormones also regulate each other directly. Insulin suppresses glucagon release, and when insulin drops, glucagon rises. The delta cells add another layer of control: somatostatin released locally within the islet dials down secretion of both insulin and glucagon, preventing either from overshooting.
What Triggers Hormone Release Beyond Food
Glucose is the primary trigger for insulin secretion, but it isn’t the only one. Amino acids from protein digestion stimulate both insulin and glucagon release. Fatty acids in the blood also influence glucagon secretion. The autonomic nervous system, the part of your nervous system that operates without conscious thought, sends signals directly to islet cells and can ramp hormone release up or down based on stress, sleep, and physical activity. Gut hormones called incretins, released by the intestinal lining when food arrives, amplify insulin secretion after meals, which is why swallowed glucose triggers more insulin than the same amount injected into a vein.
Amylin and Pancreatic Polypeptide
Beyond the big two hormones, the pancreas produces several others with meaningful metabolic effects. Amylin is co-secreted with insulin from beta cells after meals. Its primary jobs are slowing stomach emptying, reducing meal size by signaling fullness to the brain, and suppressing glucagon so the liver doesn’t dump extra glucose when it isn’t needed. Amylin also amplifies other satiety signals traveling from the gut to the brain, making you feel full sooner. There is evidence that amylin acts as a longer-term signal influencing body weight, not just individual meal size.
Pancreatic polypeptide, released by F cells, modulates how quickly the stomach moves food along and how much digestive enzyme the pancreas produces through its exocrine function. It also reduces food intake when circulating at higher levels. Much of this effect works through the vagus nerve, the major communication line between the gut and the brain.
What Happens When Endocrine Function Fails
The most common consequence of endocrine pancreatic failure is diabetes. The two major types involve different breakdowns in the system.
In type 1 diabetes, the immune system attacks and destroys beta cells. The body produces antibodies against multiple components of the islet cells, and over time, insulin production drops to near zero. Because the destruction is autoimmune, it typically begins in childhood or young adulthood and requires external insulin replacement from diagnosis onward. Without beta cells, amylin production is also lost, which contributes to the blood sugar swings and appetite changes seen in type 1 diabetes.
In type 2 diabetes, the problem starts with insulin resistance. Muscle, liver, and fat tissue stop responding normally to insulin, so the pancreas compensates by producing more. Over years, this overwork can exhaust beta cells, and insulin production eventually declines. The resistance can be observed across multiple tissues simultaneously, and the condition often progresses gradually from prediabetes (fasting blood sugar between 100 and 125 mg/dL) to full diabetes.
An A1C blood test, which reflects your average blood sugar over two to three months, is one of the standard tools for diagnosis. Normal is below 5.7%, prediabetes falls between 5.7% and 6.4%, and diabetes is diagnosed at 6.5% or higher.
How Endocrine Pancreatic Function Is Monitored
For people with diabetes, continuous glucose monitors have changed how endocrine pancreatic dysfunction is tracked day to day. Rather than relying on occasional finger-stick readings, these small sensors measure glucose levels every few minutes and report how much of the day falls within a target range. The international consensus target for adults with type 1 or type 2 diabetes is spending more than 70% of the day (roughly 17 hours) with blood sugar between 70 and 180 mg/dL. For older adults or those at higher risk of low blood sugar, the target drops to 50% or more. Each additional 5% of time spent in range is associated with meaningful health benefits, making even small improvements clinically significant.
These monitoring tools effectively give a real-time window into how well the endocrine pancreas, or its pharmaceutical replacements, is performing its core job of keeping blood sugar stable.